GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orchard Therapeutics PLC (STU:OT10) » Definitions » Other Assets for Insurance Companies

Orchard Therapeutics (STU:OT10) Other Assets for Insurance Companies


View and export this data going back to 2019. Start your Free Trial

What is Orchard Therapeutics Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Orchard Therapeutics (STU:OT10) Business Description

Industry
Traded in Other Exchanges
Address
245 Hammersmith Road, London, GBR, W6 8PW
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.